Abstract: Eisenmenger syndrome is the most severe form of pulmonary arterial hypertension and arises on the basis of congenital heart disease with a systemic-to-pulmonary shunt. Due to the chronic slow progressive hypoxemia with central cyanosis, adult patients with the Eisenmenger syndrome suffer from a complex and multisystemic disorder including co-agulation disorders (bleeding complications and paradoxical embolisms), renal dysfunction, hypertrophic osteoarthropa-thy, heart failure, reduced quality of life and premature death. For a long time, therapy has been limited to symptomatic options or lung or combined heart-lung transplantation. As new selective pulmonary vasodilators have become available and proven to be beneficial in various...
Dramatic advances in the diagnosis and treatment of congenital heart disease (CHD), the most common ...
Background: Eisenmenger syndrome (ES) is a group of symptoms caused by a congenital cardiac abnormal...
International audienceThe relationship between pulmonary arterial hypertension-specific drug therapy...
Abstract: Eisenmenger syndrome is the most severe form of pulmonary arterial hypertension and arises...
Introduction: Eisenmenger syndrome describes a condition in which a congenital heart defect has caus...
Eisenmenger syndrome (ES), the most advanced form of pulmonary arterial hypertension (PAH) associate...
Eisenmenger syndrome (ES), the most advanced form of pulmonary arterial hypertension (PAH) associate...
Heba Nashat,1–3 Aleksander Kempny,1–3 Colm McCabe,1 Laura C Price,1–3 Carl Harries...
Objective Eisenmenger syndrome (ES) is a severe form of pulmonary hypertension in adults with congen...
Objective - Pulmonary arterial hypertension (PAH), associated with congenital heart disease (CHD), u...
AIMS: Advanced therapies (prostacyclin analogues, endothelin receptor antagonists) are successfully ...
AbstractBackgroundEisenmenger syndrome (ES) in the adult population has become exceedingly rare in d...
Background This is a case report of a patient diagnosed with Eisenmenger syndrome in adult life. Cas...
Pulmonary arterial hypertension (PAH), associated with congenital heart disease (CHD), usually resul...
Eisenmenger Syndrome (ES) represents Pulmonary Arterial Hypertension (PAH) associated with Congenita...
Dramatic advances in the diagnosis and treatment of congenital heart disease (CHD), the most common ...
Background: Eisenmenger syndrome (ES) is a group of symptoms caused by a congenital cardiac abnormal...
International audienceThe relationship between pulmonary arterial hypertension-specific drug therapy...
Abstract: Eisenmenger syndrome is the most severe form of pulmonary arterial hypertension and arises...
Introduction: Eisenmenger syndrome describes a condition in which a congenital heart defect has caus...
Eisenmenger syndrome (ES), the most advanced form of pulmonary arterial hypertension (PAH) associate...
Eisenmenger syndrome (ES), the most advanced form of pulmonary arterial hypertension (PAH) associate...
Heba Nashat,1–3 Aleksander Kempny,1–3 Colm McCabe,1 Laura C Price,1–3 Carl Harries...
Objective Eisenmenger syndrome (ES) is a severe form of pulmonary hypertension in adults with congen...
Objective - Pulmonary arterial hypertension (PAH), associated with congenital heart disease (CHD), u...
AIMS: Advanced therapies (prostacyclin analogues, endothelin receptor antagonists) are successfully ...
AbstractBackgroundEisenmenger syndrome (ES) in the adult population has become exceedingly rare in d...
Background This is a case report of a patient diagnosed with Eisenmenger syndrome in adult life. Cas...
Pulmonary arterial hypertension (PAH), associated with congenital heart disease (CHD), usually resul...
Eisenmenger Syndrome (ES) represents Pulmonary Arterial Hypertension (PAH) associated with Congenita...
Dramatic advances in the diagnosis and treatment of congenital heart disease (CHD), the most common ...
Background: Eisenmenger syndrome (ES) is a group of symptoms caused by a congenital cardiac abnormal...
International audienceThe relationship between pulmonary arterial hypertension-specific drug therapy...